Crystal Structure of Cefditoren Complexed with Streptococcus pneumoniae Penicillin-Binding Protein 2X: Structural Basis for Its High Antimicrobial Activity

ABSTRACT Cefditoren is the active form of cefditoren pivoxil, an oral cephalosporin antibiotic used for the treatment of respiratory tract infections and otitis media caused by bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Klebsiella pneumoniae, and methicillin-susceptible strains of Staphylococcus aureus. β-Lactam antibiotics, including cefditoren, target penicillin-binding proteins (PBPs), which are membrane-associated enzymes that play essential roles in the peptidoglycan biosynthetic process. To envision the binding of cefditoren to PBPs, we determined the crystal structure of a trypsin-digested form of PBP 2X from S. pneumoniae strain R6 complexed with cefditoren. There are two PBP 2X molecules (designated molecules 1 and 2) per asymmetric unit. The structure reveals that the orientation of Trp374 in each molecule changes in a different way upon the formation of the complex, but each forms a hydrophobic pocket. The methylthiazole group of the C-3 side chain of cefditoren fits into this binding pocket, which consists of residues His394, Trp374, and Thr526 in molecule 1 and residues His394, Asp375, and Thr526 in molecule 2. The formation of the complex is also accompanied by an induced-fit conformational change of the enzyme in the pocket to which the C-7 side chain of cefditoren binds. These features likely play a role in the high level of activity of cefditoren against S. pneumoniae.

[1]  T. Vernet,et al.  Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in beta-lactam resistance in Streptococcus pneumoniae. , 2006, Journal of molecular biology.

[2]  G. Nicola,et al.  Crystal structure of Escherichia coli penicillin-binding protein 5 bound to a tripeptide boronic acid inhibitor: a role for Ser-110 in deacylation. , 2005, Biochemistry.

[3]  O. Dideberg,et al.  The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance. , 2000, Journal of molecular biology.

[4]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[5]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[6]  K. Wellington,et al.  Cefditoren pivoxil: a review of its use in the treatment of bacterial infections. , 2004, Drugs.

[7]  K. Ko,et al.  In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries. , 2006, International journal of antimicrobial agents.

[8]  Z. H. Li,et al.  A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Dowson,et al.  Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae. , 1995, FEMS microbiology letters.

[10]  A. Fenoll,et al.  Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones. , 2007, International journal of antimicrobial agents.

[11]  R. Hakenbeck.  Mosaic genes and their role in penicillin‐resistant Streptococcus pneumoniae (minireview) , 1998, Electrophoresis.

[12]  F. Soriano,et al.  Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project. , 2004, International journal of antimicrobial agents.

[13]  Otto Dideberg,et al.  Active site restructuring regulates ligand recognition in class A penicillin-binding proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Frère,et al.  Crystal structure of the Bacillus subtilis penicillin-binding protein 4a, and its complex with a peptidoglycan mimetic peptide. , 2007, Journal of molecular biology.

[15]  Otto Dideberg,et al.  Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. , 2006, FEMS microbiology reviews.

[16]  M. Jacobs,et al.  Activity of cefditoren against respiratory pathogens. , 2002, The Journal of antimicrobial chemotherapy.

[17]  N. Silvaggi,et al.  Structures of two kinetic intermediates reveal species specificity of penicillin-binding proteins. , 2002, Journal of molecular biology.

[18]  O. Dideberg,et al.  X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme , 1996, Nature Structural Biology.

[19]  B. Spratt,et al.  Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics. , 1994, Trends in microbiology.

[20]  F. Soriano,et al.  Antimicrobial Resistance Among Clinical Isolates of Streptococcus pneumoniae Isolated in Four Southern European Countries (ARISE Project) from Adult Patients: Results from the Cefditoren Surveillance Program , 2003, Journal of chemotherapy.

[21]  B. Matthews.  Solvent content of protein crystals. , 1968, Journal of molecular biology.

[22]  Kumiko Kondo,et al.  Complete Sequences of Six Penicillin-Binding Protein Genes from 40 Streptococcus pneumoniae Clinical Isolates Collected in Japan , 2004, Antimicrobial Agents and Chemotherapy.

[23]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[24]  J. Granizo,et al.  The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. , 2006, Clinical therapeutics.

[25]  W. Ziebuhr,et al.  Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. , 2006, International journal of antimicrobial agents.

[26]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[27]  P. Kardos,et al.  Clinical and Bacteriological Efficacy in Treatment of Acute Exacerbations of Chronic Bronchitis with Cefditoren-Pivoxil versus Cefuroxime-Axetil , 2006, Antimicrobial Agents and Chemotherapy.

[28]  K. Ubukata,et al.  Diversity of Substitutions within or Adjacent to Conserved Amino Acid Motifs of Penicillin-Binding Protein 2X in Cephalosporin-Resistant Streptococcus pneumoniaeIsolates , 1999, Antimicrobial Agents and Chemotherapy.

[29]  D. Lim,et al.  Structural analysis of an “open” form of PBP1B from Streptococcus pneumoniae , 2006, Protein science : a publication of the Protein Society.

[30]  S. Mitsuhashi,et al.  In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin , 1988, Antimicrobial Agents and Chemotherapy.

[31]  T. Yoshida,et al.  Synthesis and oral activity of ME1207, a new orally active cephalosporin. , 1990, The Journal of antibiotics.

[32]  K. Wellington,et al.  Spotlight on Cefditoren Pivoxil in Bacterial Infections , 2005, Treatments in respiratory medicine.

[33]  Samy O Meroueh,et al.  Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. , 2005, Chemical reviews.